Analyzing genetic mutations in pediatric cardiomyopathy
Official title: Pediatric Cardiomyopathy Mutation Analysis
Run by Indiana University · NCT02432092 · Data updated 2026-11-12
This study is trying to learn more about the genetic causes of heart problems in children with cardiomyopathy to help improve diagnosis and treatment options for them.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | April 2014 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT02432092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children diagnosed with cardiomyopathy and their family members.
✕Probably not a fit
Patients without cardiomyopathy or their family members are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather information from children diagnosed with various forms of cardiomyopathy and their families to better understand the genetic factors involved in this heart condition. By focusing on the molecular genetics of pediatric cardiomyopathy, the study seeks to improve diagnostic accuracy and inform future genetic counseling. The research highlights the need for precise genetic diagnosis, as outcomes in children with cardiomyopathy can vary significantly based on the underlying genetic cause. The findings may lead to enhanced management strategies and novel treatment options for affected individuals.
Why it matters
Potential benefit: If successful, this study could lead to improved genetic diagnosis and management strategies for children with cardiomyopathy.
How similar studies have gone: Previous studies have shown success in identifying genetic causes of cardiomyopathy in adults, but this approach in pediatric populations is less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects with cardiomyopathy * Family members of subjects with cardiomyopathy Exclusion Criteria: * Subjects without cardiomyopathy * Family members of subjects without cardiomyopathy
Where it's running
-
IU School of Medicine
Indianapolis, Indiana, United States Recruiting
Study contacts
- Principal investigator: Stephanie Ware, MD, PhD — IU School of Medicine
- Study coordinator: Sarah Murphy, MPH
- Email: bankssk@iu.edu
- Phone: (317) 278-3026
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observing the causes and progression of cardiomyopathy
This study is trying to understand what causes cardiomyopathy and how it gets worse by collecting DNA, blood samples, and health information from people with the condition or those at risk.
-
Identifying patients with cardiomyopathy for potential heart transplantation
This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.
-
Study of heart conditions using advanced imaging techniques
This study is trying to find out what causes different heart conditions in Hispanic and African American people in the Bronx by using advanced imaging techniques.
-
Hypertrophic Cardiomyopathy Registry, Biobank, and Imaging Data Repository
This project tests whether collecting genetic, imaging, and clinical data from people with hypertrophic cardiomyopathy can help predict outcomes and better understand the disease.
-
A quick 10-minute heart scan for cardiac diseases
This study is testing a quick 10-minute heart scan to see if it can help diagnose heart problems better and faster for many patients without needing special dyes.
-
Registry and biobank for arrhythmogenic ventricular cardiomyopathy
This study is trying to gather information and samples from people with arrhythmogenic ventricular cardiomyopathy and their families to better understand the genetic causes of the condition and improve early diagnosis for those at risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.